Peptide Solubility and Aggregation in the Laboratory

A lyophilized peptide that refuses to dissolve, or dissolves and then turns faintly cloudy overnight, is one of the most common frustrations in peptide work. Peptide solubility and aggregation are governed by the same few properties of the sequence: net charge, hydrophobicity, and the tendency of the backbone to assemble into beta-sheet structures. This article explains how to predict solubility from a sequence, how to choose a solvent strategy for in-vitro stock solutions, and how to detect aggregates before they distort an assay. The hydrophilic heptapeptide Selank serves as the easy-case example.

What controls peptide solubility

Net charge and pH. Solubility is lowest near a peptide's isoelectric point, where positive and negative charges balance and nothing stops molecules associating. Moving the pH away from that point increases net charge and electrostatic repulsion. Substitution studies in RNase Sa and a comparison of seven proteins both link solubility to surface charge, with increased negative surface charge correlating strongly with higher solubility [4, 5].

Residue identity. Not all hydrophilic residues are equal. Substitution work on RNase Sa found that aspartate, glutamate and serine contributed more favourably to solubility than other hydrophilic residues [4]. Conversely, runs of Leu, Ile, Val, Phe, Trp and Met reduce solubility and favour self-association.

Secondary structure propensity. Sequences that readily form beta-strands can assemble into ordered aggregates, from small oligomers to amyloid-like fibrils. A review of peptide physical stability lists sequence, concentration, pH, net charge, excipients, chemical degradation, surfaces, impurities, temperature, agitation and lyophilization as factors that shift the balance [1].

Counterions and salts. The salt form alters the pH on dissolution and can change aggregation behaviour. Adding salt screens charge repulsion, so a peptide soluble in water may precipitate in a high-ionic-strength buffer.

Reading a sequence before you add solvent

A quick assessment takes a minute:

1. Count charges at the working pH. Assign +1 for Lys, Arg and a free N-terminus; +1 for His below about pH 6; -1 for Asp, Glu and a free C-terminus. Amidated C-termini and acetylated N-termini carry no charge.
2. Estimate hydrophobic content. If hydrophobic residues exceed roughly half the sequence, expect difficulty in purely aqueous solvent.
3. Note special residues. Cys can form intermolecular disulfides; Met, Cys and Trp are oxidation-prone and affect solvent choice.

Worked example: Selank, a highly soluble sequence

Selank is the heptapeptide Thr-Lys-Pro-Arg-Pro-Gly-Pro, an analogue of the tetrapeptide tuftsin extended with a Pro-Gly-Pro tail. At neutral pH it carries two positive side chains (Lys, Arg) and a free N-terminus against a single free C-terminal carboxylate, giving a net charge of about +2. It contains no strongly hydrophobic residues, and its three prolines disfavour regular beta-sheet formation. Every rule above points the same way: Selank dissolves readily in water or dilute aqueous acid, and aggregation is unlikely to be the main stability concern. For sequences like this, chemical degradation and surface adsorption at low concentration matter more than solubility.

Contrast this with a neutral 15-residue sequence rich in Leu, Val and Phe. There, water alone may produce a suspension, and the order of solvent addition becomes important.

A solvent strategy for in-vitro stock solutions

The general approach is to start with the mildest solvent that can work and escalate only if needed, always testing on a small portion of the material first.

Peptide character	First choice	If that fails
Net positive (basic)	Sterile water	Dilute acetic acid (for example 10%), then dilute into buffer
Net negative (acidic)	Sterile water	Dilute ammonium bicarbonate or ammonium hydroxide, then buffer
Neutral, hydrophilic	Water or buffer	Small share of acetonitrile or methanol
Neutral, hydrophobic	Minimal DMSO or DMF to wet and dissolve	Dilute slowly into aqueous buffer with mixing

Several practical points apply regardless of the table:

• Dissolve concentrated, then dilute. Adding a small volume of the effective solvent first, then diluting, works better than adding the full aqueous volume at once.
• Mind the co-solvent in the assay. Record final DMSO or acid content and include a matched vehicle control.
• Avoid DMSO with free cysteines or methionine where possible, since it can promote oxidation.
• Brief sonication in a water bath can break up clumps; avoid prolonged heating.
• Centrifuge before use. Spin the solution and use the supernatant if any particulate is visible, then confirm concentration.

For a fuller discussion of solvents, including bacteriostatic water, see reconstitution solvents for peptide research.

Record what worked

Solubility behaviour is lot- and salt-dependent, so it pays to write it down. Note the solvent, its pH, the final concentration, the order of addition, how long the material took to clear and how the solution looked after an hour and after overnight storage. After dissolving, confirm the concentration rather than assuming it from the weighed mass: a portion that stayed undissolved on the vial wall, or a fraction lost to a spin-down, changes the true value. Our guide to calculating peptide stock solution concentrations covers the arithmetic and the correction for net peptide content.

Detecting aggregation

Aggregates can be amorphous or ordered, and soluble oligomers are often invisible by eye [1, 2]. Useful checks include:

• Visual inspection and turbidity at 340 to 400 nm, which catch larger aggregates.
• Dynamic light scattering, which detects species from nanometres upward.
• Size-exclusion chromatography, which separates monomer from oligomers and can quantify them.
• Thioflavin T fluorescence. ThT fluoresces strongly when bound to cross-beta structures. Reviews of its mechanism tie the large fluorescence enhancement to binding on the cross-beta surface of fibrils, which explains its selectivity [3]. ThT is sensitive to amyloid-like aggregates but does not report amorphous ones.
• Loss of the main HPLC peak after filtration or centrifugation, which indicates material removed as insoluble aggregate.

Surfaces and handling

Peptides lost to surfaces can look like peptides lost to aggregation. A study of eight radiolabelled endocrine peptides found large differences in the amount remaining in solution across glass and plastic tubes; siliconization made matters worse, while 1% bovine serum albumin improved the amount retained [6]. Low-binding plastics, carrier protein where the assay allows, and avoiding long holds at very low concentrations all help. Freezing and thawing add their own stresses, covered in freeze-thaw cycles and aliquoting peptide stocks.

Key takeaways

• Net charge, hydrophobicity and beta-sheet propensity largely determine peptide solubility and aggregation.
• Work away from the isoelectric point: dilute acid for basic peptides, dilute base for acidic ones, minimal organic solvent for hydrophobic ones.
• Short, charged, proline-rich sequences such as Selank are generally easy to dissolve.
• A clear solution is not proof of monomeric peptide; use light scattering, SEC or ThT where it matters.
• Surface adsorption can mimic aggregation, particularly at low concentrations.

This article summarizes published research for informational purposes. All Ascent Sciences products are for laboratory research use only and are not for human or animal consumption.

References

1. Zapadka KL, Becher FJ, Gomes Dos Santos AL, et al. Factors affecting the physical stability (aggregation) of peptide therapeutics. Interface Focus. 2017;7(6):20170030. PubMed
2. Frokjaer S, Otzen DE. Protein drug stability: a formulation challenge. Nat Rev Drug Discov. 2005;4(4):298-306. PubMed
3. Biancalana M, Koide S. Molecular mechanism of Thioflavin-T binding to amyloid fibrils. Biochim Biophys Acta. 2010;1804(7):1405-1412. PubMed
4. Trevino SR, Scholtz JM, Pace CN. Amino acid contribution to protein solubility: Asp, Glu, and Ser contribute more favorably than the other hydrophilic amino acids in RNase Sa. J Mol Biol. 2007;366(2):449-460. PubMed
5. Kramer RM, Shende VR, Motl N, et al. Toward a molecular understanding of protein solubility: increased negative surface charge correlates with increased solubility. Biophys J. 2012;102(8):1907-1915. PubMed
6. Goebel-Stengel M, Stengel A, Taché Y, et al. The importance of using the optimal plasticware and glassware in studies involving peptides. Anal Biochem. 2011;414(1):38-46. PubMed